Iselin, NJ Hilton Woodbridge May 16 – 17, 2012 2012 Pharmaceutical/Biotech Accounting & Reporting Update Conference Get the most recent updates on changing regulations, industry trends and the latest life sciences accounting and reporting best practices. Discover how health care reform, the credit crisis, the SEC and international tax planning will impact the financial reporting of pharma- ceutical and biotech companies. Plus, gain technical guidance from top level pharmaceutical finance officers and government regulators in this highly focused two- day conference. Designed for financial professionals in the pharmaceutical and biotechnology industries. AGENDA HIGHLIGHTS < The current environment and key emerging trends < Health care reform update < Regulatory update: aggregate spend reporting and the Sunshine Act < Deal-making in the industry < M&A activity: current trends and expectations in the industry < Valuation considerations < FASB and technical accounting update < Revenue recognition and leases < Leadership in pharmaceuticals and biotechnology < Projecting pharmaceutical business trends < Outlook for the global pharmaceuticals industry • SEC comment letters AMERICA’S LEADER IN CONTINUING PROFESSIONAL EDUCATION THIS PROGRAM WILL BE SIMULTANEOUSLY PRESENTED AS A LIVE WEBCAST Register Today < 1-800-544-1114
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.